EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prolonged Corrected QT Interval as an Early Electrocardiographic Marker of Cyclophosphamide‐Induced Cardiotoxicity in Pediatric Hematology and Oncology Patients

Junpei Kawamura, Kentaro Ueno, Takuro Nishikawa, Yoshihiro Takahashi, Koji Nakae, Yasuhiro Okamoto

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Junpei Kawamura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Cyclophosphamide, Electrocardiography, Cardiotoxicity, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cyclophosphamide (CY) is associated with potentially fatal cardiotoxicity, yet no electrocardiographic indices have been established for early detection of CY‐induced cardiomyopathy. This study aimed to determine whether corrected QT interval (QTc) prolongation can predict early onset of CY‐related cardiac dysfunction in pediatric patients.

Methods

We retrospectively analyzed 62 children who received high‐dose CY therapy (≥100 mg/kg) for hematologic or oncologic diseases between 2010 and 2025. CY‐induced cardiomyopathy was defined as a ≥10% reduction in the left ventricular ejection fraction to less than 50% or elevated brain natriuretic peptide/ N ‐terminal pro‐brain natriuretic peptide levels, according to the 2021 International Cardio‐Oncology Society criteria. Resting 12‐lead ECGs were obtained before and within 24 h of CY administration. QTc was calculated using the Fridericia and Bazett formulas, and ΔQTc (post–pre) was evaluated using logistic regression and receiver operating characteristic (ROC) analyses.

Results

Seven (11.3%) patients developed CY‐induced cardiomyopathy. QTc after CY administration and ΔQTc were significantly greater in the cardiomyopathy group ( p < 0.001). In multivariate analysis, ΔQTc was independently associated with cardiomyopathy (odds ratio 2.21, 95% confidence interval [CI]: 1.26–3.90, p = 0.0060). ROC analysis revealed excellent predictive accuracy (area under the curve = 0.96), with a ΔQTc ≥30.5 ms yielding 100% sensitivity and 89.1% specificity. Progressive QTc prolongation was also observed from pre‐ to post‐CY and at diagnosis in the affected patients.

Conclusions

QTc prolongation within 24 h of CY administration suggests subsequent CY‐induced cardiomyopathy in children. ΔQTc may serve as an early, noninvasive marker for timely detection and intervention in CY‐induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideElectrocardiographyCardiotoxicityCardiomyopathiesLong QT SyndromeNeoplasmsHematologic NeoplasmsAntineoplastic Agents, AlkylatingHumansFemaleMaleRetrospective StudiesChildChild, PreschoolAdolescentFollow-Up StudiesInfantPrognosisBiomarkers

Stichwörter der Autor:innen

CTCRDQTccyclophosphamideelectrocardiographypediatric

Substanzen

CyclophosphamideBiomarkersAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Zitieren

APA

Kawamura, J., Ueno, K., Nishikawa, T., Takahashi, Y., Nakae, K., & Okamoto, Y. (2026). Prolonged Corrected QT Interval as an Early Electrocardiographic Marker of Cyclophosphamide‐Induced Cardiotoxicity in Pediatric Hematology and Oncology Patients. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70102

Vancouver

Kawamura J, Ueno K, Nishikawa T, Takahashi Y, Nakae K, Okamoto Y. Prolonged Corrected QT Interval as an Early Electrocardiographic Marker of Cyclophosphamide‐Induced Cardiotoxicity in Pediatric Hematology and Oncology Patients. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70102

BibTeX
@article{Kawamura2026,
  author = {Kawamura, Junpei and Ueno, Kentaro and Nishikawa, Takuro and Takahashi, Yoshihiro and Nakae, Koji and Okamoto, Yasuhiro},
  title = {Prolonged Corrected QT Interval as an Early Electrocardiographic Marker of Cyclophosphamide‐Induced Cardiotoxicity in Pediatric Hematology and Oncology Patients},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70102}
}
Kostenlos starten →